References
- Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G: Cholinergic transmission. In: Pharmacology 5th edition (ed. Rang HP, Maureen Dale M). Churchill Livingstone: Philadelphia, 2003; 145-147.
- Clode A: Clinical pharmacology and therapeutics. In: Veterinary Ophthalmology 5th edition (Gelatt KN, Gilger CG, Kern TJ, eds.). John Wiley & Sons Inc: Iowa, 2013; 423-434.
- Glasser A: Accommodation. In: Adler’s Physiology of the Eye 11th edition (Levin LA, ed.) Elsevier Inc: Philadelphia: Elsevier Inc., 2011; 40-70.
- Ansari Mood M, Rajaei SM, Faghihi H, Ghiadi A: Effect of topical 1% cyclopentolate hydrochloride on tear production, intraocular pressure, and pupil size in healthy Turkman horses. J Equine Vet Sci 2019, 75:25-29.
- Ganesh S, Arora P, Sethi S, Gurung C: Cycloplegic Refraction in children: a complete audit cycle. Open J Ophthalmol 2015, 5:41-45.
- Kovalcuka L, Nikolajenko M: Changes in intraocular pressure, horizontal pupil diameter, and tear production during the use of topical 1% cyclopentolate in cats and rabbits. Open Vet J 2020, 10(1):59-67.
- Costa D, Leiva M, Coyo N, Laguna F, Ríos J, Peña Gimenez MT: Effect of topical 1% cyclopentolate hydrochloride on tear production, pupil size, and intraocular pressure in healthy Beagles. Vet Ophthalmol 2016, 19(6):449-453.
- Stadtbaumer K, Frommlet F, Nell B: Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye. Vet Ophthalmol 2006, 9:233-237.
- Murphy CJ, Zadnik K, Mannis MJ: Myopia and refractive error in dogs. Invest Ophthalmol Vis Sci 1992, 33(8):2459-2463.
- Konrade KA, Hoffman AR, Ramey KL, Goldenberg RB, Lehenbauer TW: Refractive states of eyes and associations between ametropia and age, breed, and axial globe length in domestic cats. Am J Vet Res 2012, 73(2):279-284.
- Hancox J, Murdoch I, Parmar D: Changes in intraocular pressure following diagnostic mydriasis with cyclopentolate 1%. Eye 2002, 16:562-566.
- Hollingsworth SR, Canton DD, Buyukmihci NC, Farver TB: Effect of topically administered atropine on tear production in dogs. J Am Vet Med Assoc 1992, 200(10):1481-1484.
- Margadant DL, Kirkby K, Andrew SE, Gelatt KN: Effect of topical tropicamide on tear production as measured by Schirmer’s tear test in normal dogs and cats. Vet Ophthalmol 2003, 6(4):315-320.
- Ribeiro AP, Crivelaro RM, Teixeira PP, Trujillo DY, Guimarães PJ, Vicente WR, Martins Bda C, Laus JL: Effects of different mydriatics on intraocular pressure, pupil diameter, and ruminal and intestinal motility in healthy sheep. Vet Ophthalmol 2014, 17(6):397-402.
- Ortillés Á, Sanmartí J, Ríos J, Armengou L, Peña MT, Leiva M: Effects of topical 1% cyclopentolate hydrochloride on quantitative pupillometry measurements, tear production and intraocular pressure in healthy horses. Vet Ophthalmol 2020, 23(4):730–739.
- Salminen L: Review: systemic absorption of topically applied ocular drugs in humans. J Ocular Pharmacol 1990, 6:243-249.
- Rajeev A, Gupta G, Adhikari KM, Yadav AK, Sathyamoorthy M: Neurotoxic effects of topical cyclopentolate. Med J Armed Forces India 2010, 66(3):288-289.
- Bedirli N, Akgün F, Hondur A, Işık B: Suspected central anticholinergic syndrome related to cycloplegic eye drop in a premature baby. Balkan Med J 2012, 29(3):326-327.
- Bessonnat A, Vanore M: Effect of topical cyclopentolate alone or combined with phenylephrine in healthy horses. Vet Ophthalmol 2021, 24(6):582-590.
- Bhatia SS, Vidyashankar C, Sharma RK, Dubey AK: Systemic toxicity with cyclopentolate eye drops. Indian Pediatr 2000, 37(3):329-331.
- Hakim KT, Huupponen R, Salminen L, Iisalo E: Systemic absorption of ophthalmic cyclopentolate. Am J Ophthalmol 1989, 107:562-564.
- Bartlett JD: Mydriatics and cycloplegics. In: Ophthalmic Drug Facts (ed. Bartlett JD). Wolters Kluwer Health Inc.: St. Louis, 2004; 41-45.
- Isenberg SJ, Abrams C, Hyman, PE: Effects of cyclopentolate eyedrops on gastric secretory function in preterm infants. Ophthalmology 1985, 92:698-700.
- Kubai MA, Bentley E, Miller PE, et al. Ref ractive states of eyes and association between ametropia and breed in dogs. American Journal of Veterinary Research 2008; 69: 946-951.
- Calisaneller T, Ozdemir O, Sonmez E, Altinors N: Acute progressive midbrain hemorrhage after topical ocular cyclopentolate administration. Neurol India 2008, 56(1):88–89
- Elibol O, Alçelik T, Yüksel N, Caglar Y: The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants. Acta Ophthalmol Scand 1997, 75(2):178-180.
- Roy AK, Guillory J K: The kinetics and mechanism of the hydrolysis of cyclopentolate hydrochloride in alkaline solutions. Int J Pharmaceutics 1995, 120:169-170.
- Court MH: Feline drug metabolism and disposition pharmacokinetic evidence for species differences and molecular mechanisms. Vet Clin Small Anim 2013, 43:1039-1054.
- Baiza-Durán LM, González JR, Tornero Montaño R: Estudio clínico comparativo de la eficiencia de tres concentraciones de fenilefrina tópica oftálmica en población pediátrica. Revista Mexicana de Oftalmología 2005, 79:211-214.
- Alghamdi WM, Alrasheed SH, Nair V, Alluwimi MS. Effects of Cyclopentolate Hydrochloride Dosage on Anterior Segment Parameters in Young Adults (Measured with Pentacam). Clin Ophthalmol. 2021 Mar 1;15:891-898.
- Khoo BK, Koh A, Cheong P, Ho NK. Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides. J Pediatr Ophthalmol Strabismus. 2000 Jan-Feb;37(1):15-20. doi: 10.3928/0191-3913-20000101-05. PMID: 10714690.
- Brenner RL: Pupillary dilatation with single-eyedrop mydriatic combinations. Am J Ophthalmol 1980, 90:271272.
- Hug T, Olitsky S: Dilation efficacy: Is 1% cyclopentolate enough? Optometry 2007, 78:119-121.
- Huupponen R, Kaila T, Saettone MF, Monti D, Ilsalo E, Salminen L, Oksala O. The effect of some macromolecular ionic complexes on the pharmacokinetics and – dynamics of ocular cyclopentolate in rabbits. J Ocul Pharmacol. 1992 Spring;8(1):59-67.
- Mirshahi A, Kohnen T: Acute psychotic reaction caused by topical cyclopentolate use for cycloplegic refraction before refraction surgery. J Cataract Refractive Surg 2003, 29:1026-1030.